-
Y-27632 Dihydrochloride Stem Cell Workflows
2026-08-26
Y-27632 dihydrochloride is a selective ROCK inhibitor for improving post-dissociation cell recovery, dissecting cytoskeletal remodeling, and testing invasion-related phenotypes. This workflow connects transient ROCK inhibition with the long-term myogenic engraftment model reported for human pluripotent stem cell-derived progenitors, while separating evidence-based findings from practical assay recommendations.
-
2,5-di-tert-butylbenzene-1,4-diol (BHQ) Workflows
2026-08-26
Use BHQ to connect SERCA inhibition with measurable calcium-store depletion, ER stress, and downstream cell behavior. This practical guide covers calcium imaging, HSC mobilization assays, and vascular smooth muscle studies with formulation, controls, and troubleshooting guidance.
-
Radiotherapy, PD-1/TIGIT Blockade, and CD8+ Memory
2026-08-25
The reference study shows that radiotherapy combined with PD-1 and TIGIT blockade can extend local tumor control to untreated lesions and establish durable immune memory in mouse models. Its mechanistic contribution is the integration of CD8+ T-cell profiling, macrophage state analysis, cytokine measurements, and adoptive-transfer experiments to connect abscopal activity with sustained cellular immunity.
-
YM 58483 (BTP2): SOCE Assay Design
2026-08-25
YM 58483, also called BTP2, is a powerful tool for resolving how sustained store-operated calcium entry connects immune signaling with tissue remodeling. This article translates recent salivary-gland fibrosis findings into practical assay-design decisions while defining the limits of pharmacologic SOCE interpretation.
-
Chrysin, Ferroptosis, and Sunitinib Sensitivity in RCC
2026-08-24
Chen and colleagues report that chrysin increases sunitinib sensitivity in renal cell carcinoma by promoting ferroptosis through suppression of the PI3K/Akt/GPX4 axis. The study integrates computational target prioritization with cellular validation, offering a mechanistic framework for studying flavonoid-based strategies against sunitinib resistance while leaving important translational questions unresolved.
-
(-)-Norepinephrine (+)-bitartrate: Applied Workflows
2026-08-23
Build reproducible adrenergic assays and vascular models with a fresh, light-protected norepinephrine workflow. The compound is especially useful for connecting receptor activation with blood pressure regulation, renal vascular reactivity, and cardiomyopathy research.
-
ML-7 Hydrochloride: From Pathway to Assay
2026-08-22
ML-7 hydrochloride is a myosin light chain kinase inhibitor used to dissect contractility, barrier regulation, and cellular invasion. This article connects cardiovascular models with mechanistic assay design and explains how phosphorylation-centered controls improve interpretation.
-
DAPI Nuclear Stain Solution: Practical Guide
2026-08-21
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution, SKU K2402, provides a ready-to-use fluorescent DNA binding dye for nuclear visualization and membrane-integrity assessment. It is best suited to fixed or membrane-compromised samples analyzed by fluorescence microscopy or flow cytometry, not routine live-cell nuclear imaging.
-
QPRT, P2Y11, and Breast Cancer Invasion
2026-08-21
Liu et al. show that quinolinate phosphoribosyltransferase (QPRT), a NAD+ biosynthetic enzyme, is associated with invasive breast cancer and promotes migration and invasion through a purinergic signaling network linked to myosin light-chain phosphorylation. Genetic and pharmacological perturbation supports a QPRT–P2Y11–Rho/ROCK–PLC/MLCK axis, while also highlighting the need for receptor-specific validation.
-
IL-1β–NF-κB Control of ACE2 in Macrophage Infection
2026-08-20
This preprint proposes that IL-1β-driven NF-κB activity dynamically increases ACE2 expression in macrophages, creating a route to SARS-CoV-2 infection that is not apparent from baseline receptor expression alone. A native-promoter humanized ACE2 mouse model showed pulmonary infection with a more resilient phenotype than the K18-hACE2 model, offering a framework for separating viral susceptibility from fulminant disease.
-
Annexin V-Cy5/DAPI Apoptosis Kit: Assay Logic
2026-08-20
The Annexin V-Cy5/DAPI Apoptosis Kit supports rapid apoptosis and necrosis analysis while preserving the distinction between membrane events and mitochondrial mechanism. This evidence-driven guide explains how to interpret K2255 data in Ph+ ALL and drug-response experiments.
-
Hypoxia, Choroid Plexus, and Cognitive Impairment
2026-08-19
This study identifies choroid plexus blood–cerebrospinal fluid barrier disruption as a central event linking simulated high-altitude hypoxia to cognitive dysfunction in mice. Its proposed cascade connects aberrant AMPK signaling and oxidative stress with M1 macrophage polarization, offering a barrier- and immune-centered framework for studying hypoxic CNS injury.
-
Vina-Ginsenoside R18: Dual-Target Dengue Inhibitor
2026-08-19
A 2025 study identifies vina-ginsenoside R18 as a dual-target dengue antiviral that interferes with both envelope-protein-mediated adsorption and RNA replication. Its value lies in linking two mechanistically distinct stages of infection, although additional pharmacological, serotype-specific, and clinical studies are needed.
-
Norepinephrine Formulations in Critical Care Research
2026-08-18
The SCCM–ESICM position paper identifies a consequential but often overlooked source of variability: norepinephrine may be labeled and dosed as a conjugated salt or as norepinephrine base. Its central contribution is a global reporting framework intended to improve dose interpretation, patient safety, clinical decision-making, and comparability across critical care studies.
-
3X FLAG Peptide: Assay Design for Rigor
2026-08-17
The 3X (DYKDDDDK) Peptide is more than a high-signal FLAG reagent: it is a practical tool for separating antibody recognition, protein recovery, and mechanistic claims. This guide connects its chemistry to assay controls, metal sensitivity, structural biology, and lessons from nimbolide chemoproteomics.
455 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page